| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.806 | 0.002 | 0.806 | Peroxidase inhibitor | 0.395 0.021 CID_124202061 | ||
| 0.684 | 0.004 | 0.684 | GABA C receptor rho-3 antagonist | |||
| 0.634 | 0.011 | 0.634 | 5 Hydroxytryptamine release stimulant | 0.479 0.031 CID_124202061 | ||
| 0.609 | 0.018 | 0.609 | Aldehyde oxidase inhibitor | |||
| 0.619 | 0.034 | 0.62 | Caspase 9 stimulant | 0.62 0.033 CID_124202061 | CID_124202061 | |
| 0.55 | 0.013 | 0.55 | Calcium channel L-type activator | 0.385 0.091 CID_124202061 | ||
| 0.534 | 0.011 | 0.534 | Dyrk kinase inhibitor | |||
| 0.529 | 0.01 | 0.529 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.537 | 0.02 | 0.537 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.504 | 0.007 | 0.504 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.492 | 0.032 | 0.686 | Histamine release inhibitor | 0.686 0.005 CID_124202061 | CID_124202061 | |
| 0.469 | 0.027 | 0.469 | MAP kinase kinase 6 inhibitor | |||
| 0.461 | 0.047 | 0.542 | 5 Hydroxytryptamine release inhibitor | 0.542 0.021 CID_124202061 | CID_124202061 | |
| 0.397 | 0.004 | 0.397 | GABA C receptor rho-2 antagonist | |||
| 0.417 | 0.024 | 0.417 | Superoxide dismutase inhibitor | |||
| 0.42 | 0.028 | 0.42 | Interleukin antagonist | 0.212 0.078 CID_124202061 | ||
| 0.407 | 0.017 | 0.407 | RNA-directed DNA polymerase inhibitor | 0.345 0.025 CID_124202061 | ||
| 0.419 | 0.034 | 0.419 | Aryl hydrocarbon receptor agonist | |||
| 0.43 | 0.046 | 0.451 | Vasodilator, peripheral | 0.451 0.04 CID_124202061 | CID_124202061 | |
| 0.406 | 0.024 | 0.406 | Amyloid beta aggregation inhibitor | 0.298 0.045 CID_124202061 | ||
| 0.467 | 0.085 | 0.652 | Apoptosis agonist | 0.652 0.039 CID_124202061 | CID_124202061 | |
| 0.398 | 0.021 | 0.398 | Pyruvate kinase inhibitor | |||
| 0.4 | 0.025 | 0.4 | Calcium channel activator | |||
| 0.383 | 0.01 | 0.383 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.401 | 0.029 | 0.652 | Free radical scavenger | 0.652 0.006 CID_124202061 | CID_124202061 | |
| 0.349 | 0.005 | 0.794 | Beta glucuronidase inhibitor | 0.794 0.002 CID_124202061 | CID_124202061 | |
| 0.366 | 0.022 | 0.591 | Cyclic AMP phosphodiesterase inhibitor | 0.591 0.004 CID_124202061 | CID_124202061 | |
| 0.364 | 0.02 | 0.364 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.374 | 0.034 | 0.401 | DNA damaging | 0.401 0.028 CID_124202061 | CID_124202061 | |
| 0.361 | 0.025 | 0.361 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.349 | 0.015 | 0.349 | Tubulin antagonist | |||
| 0.35 | 0.026 | 0.35 | Death-associated protein kinase 3 inhibitor | |||
| 0.328 | 0.004 | 0.328 | Phenylalanine 4-hydroxylase inhibitor | 0.061 0.056 CID_124202061 | ||
| 0.383 | 0.059 | 0.383 | Angiogenesis inhibitor | 0.374 0.062 CID_124202061 | ||
| 0.33 | 0.008 | 0.33 | GABA C receptor agonist | |||
| 0.334 | 0.013 | 0.433 | NOS3 expression enhancer | 0.433 0.007 CID_124202061 | CID_124202061 | |
| 0.346 | 0.027 | 0.346 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.334 | 0.015 | 0.334 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.345 | 0.027 | 0.345 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.332 | 0.015 | 0.332 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.334 | 0.02 | 0.569 | DNA methylase inhibitor | 0.569 0.004 CID_124202061 | CID_124202061 | |
| 0.337 | 0.024 | 0.337 | MAP kinase kinase 2 inhibitor | |||
| 0.321 | 0.008 | 0.331 | Nitric-oxide synthase stimulant | 0.331 0.006 CID_124202061 | CID_124202061 | |
| 0.346 | 0.033 | 0.346 | Antimitotic | 0.157 0.115 CID_124202061 | ||
| 0.32 | 0.012 | 0.32 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.312 | 0.004 | 0.312 | Creatine kinase inhibitor | 0.09 0.072 CID_124202061 | ||
| 0.383 | 0.082 | 0.383 | 15-Lipoxygenase inhibitor | |||
| 0.337 | 0.039 | 0.337 | Insulysin inhibitor | |||
| 0.301 | 0.005 | 0.301 | Protein kinase C zeta inhibitor | |||
| 0.298 | 0.004 | 0.298 | GABA C receptor antagonist | |||
| 0.339 | 0.049 | 0.675 | Antioxidant | 0.675 0.007 CID_124202061 | CID_124202061 | |
| 0.309 | 0.025 | 0.309 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.29 | 0.008 | 0.29 | Death-associated protein kinase 2 inhibitor | |||
| 0.312 | 0.032 | 0.312 | EphB2 antagonist | |||
| 0.3 | 0.026 | 0.5 | DNA methyltransferase I inhibitor | 0.5 0.005 CID_124202061 | CID_124202061 | |
| 0.287 | 0.014 | 0.299 | NADPH oxidase inhibitor | 0.299 0.013 CID_124202061 | CID_124202061 | |
| 0.279 | 0.008 | 0.279 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.29 | 0.02 | 0.29 | Vascular endothelial growth factor 3 antagonist | |||
| 0.279 | 0.012 | 0.279 | Cystathionine beta-synthase inhibitor | 0.248 0.015 CID_124202061 | ||
| 0.293 | 0.026 | 0.293 | Protein kinase C nu inhibitor | |||
| 0.404 | 0.137 | 0.796 | Antiinflammatory | 0.796 0.016 CID_124202061 | CID_124202061 | |
| 0.268 | 0.004 | 0.268 | GABA C receptor rho-1 antagonist | |||
| 0.299 | 0.039 | 0.299 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.285 | 0.029 | 0.285 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.258 | 0.004 | 0.258 | Myeloperoxidase inhibitor | |||
| 0.258 | 0.006 | 0.258 | Protein kinase C gamma inhibitor | 0.129 0.045 CID_124202061 | ||
| 0.274 | 0.026 | 0.274 | I kappa B kinase epsilon inhibitor | |||
| 0.252 | 0.005 | 0.252 | Interleukin 8 antagonist | 0.104 0.087 CID_124202061 | ||
| 0.253 | 0.007 | 0.253 | Porphobilinogen synthase inhibitor | |||
| 0.262 | 0.022 | 0.262 | MAP kinase kinase 3 inhibitor | |||
| 0.272 | 0.033 | 0.272 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.22 0.058 CID_124202061 | ||
| 0.267 | 0.03 | 0.31 | Neurotrophic factor enhancer | 0.31 0.015 CID_124202061 | CID_124202061 | |
| 0.244 | 0.009 | 0.244 | Histidine decarboxylase inhibitor | |||
| 0.251 | 0.018 | 0.251 | Aldehyde dehydrogenase inhibitor | 0.243 0.019 CID_124202061 | ||
| 0.26 | 0.028 | 0.26 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.236 | 0.008 | 0.236 | Protein kinase C mu inhibitor | |||
| 0.245 | 0.019 | 0.245 | Interleukin 1 antagonist | 0.12 0.089 CID_124202061 | ||
| 0.265 | 0.041 | 0.265 | CDC-like kinase 2 inhibitor | |||
| 0.244 | 0.019 | 0.244 | CDC-like kinase 1 inhibitor | |||
| 0.246 | 0.022 | 0.246 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.229 | 0.005 | 0.229 | Protein kinase C delta inhibitor | 0.092 0.06 CID_124202061 | ||
| 0.232 | 0.011 | 0.232 | Carbonic anhydrase III inhibitor | 0.145 0.03 CID_124202061 | ||
| 0.268 | 0.048 | 0.268 | Clk dual-specificity kinase inhibitor | |||
| 0.226 | 0.009 | 0.226 | 5 Hydroxytryptamine 3A agonist | |||
| 0.222 | 0.006 | 0.222 | Prolactin inhibitor | |||
| 0.224 | 0.011 | 0.224 | CF transmembrane conductance regulator agonist | 0.16 0.06 CID_124202061 | ||
| 0.236 | 0.028 | 0.236 | Succinate dehydrogenase inhibitor | |||
| 0.301 | 0.094 | 0.707 | Transcription factor NF kappa B inhibitor | 0.707 0.02 CID_124202061 | CID_124202061 | |
| 0.25 | 0.043 | 0.25 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.231 | 0.025 | 0.231 | Neurotensin receptor agonist | |||
| 0.237 | 0.032 | 0.599 | Amylase inhibitor | 0.599 0.004 CID_124202061 | CID_124202061 | |
| 0.259 | 0.055 | 0.259 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.231 | 0.026 | 0.327 | Alpha-N-acetylglucosaminidase inhibitor | 0.327 0.014 CID_124202061 | CID_124202061 | |
| 0.343 | 0.14 | 0.343 | MAP kinase 1 inhibitor | |||
| 0.243 | 0.041 | 0.243 | LIM domain kinase 1 inhibitor | |||
| 0.252 | 0.051 | 0.252 | ErbB-1 antagonist | |||
| 0.224 | 0.025 | 0.224 | MAO A inhibitor | |||
| 0.203 | 0.006 | 0.203 | DOPA decarboxylase inhibitor | |||
| 0.221 | 0.024 | 0.356 | ATPase inhibitor | 0.356 0.004 CID_124202061 | CID_124202061 | |
| 0.256 | 0.063 | 0.409 | DNA synthesis inhibitor | 0.409 0.02 CID_124202061 | CID_124202061 | |
| 0.222 | 0.03 | 0.262 | Interleukin 6 antagonist | 0.262 0.021 CID_124202061 | CID_124202061 | |
| 0.203 | 0.012 | 0.203 | Adenylate cyclase stimulant | 0.15 0.062 CID_124202061 | ||
| 0.204 | 0.013 | 0.204 | Carbonic anhydrase VI inhibitor | 0.106 0.036 CID_124202061 | ||
| 0.207 | 0.021 | 0.207 | Toll-Like receptor 2 antagonist | |||
| 0.278 | 0.093 | 0.278 | 12-Lipoxygenase inhibitor | |||
| 0.22 | 0.034 | 0.366 | Lipid peroxidase inhibitor | 0.366 0.012 CID_124202061 | CID_124202061 | |
| 0.274 | 0.093 | 0.333 | Caspase 3 stimulant | 0.333 0.065 CID_124202061 | CID_124202061 | |
| 0.223 | 0.044 | 0.223 | Lipocortins synthesis antagonist | 0.173 0.078 CID_124202061 | ||
| 0.254 | 0.074 | 0.254 | Gastrin inhibitor | |||
| 0.192 | 0.015 | 0.192 | Protein kinase A inhibitor | |||
| 0.182 | 0.004 | 0.182 | Protein kinase C theta inhibitor | |||
| 0.248 | 0.072 | 0.39 | Antiamyloidogenic | 0.39 0.03 CID_124202061 | CID_124202061 | |
| 0.213 | 0.038 | 0.213 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.181 | 0.008 | 0.181 | Alcohol oxidase inhibitor | |||
| 0.194 | 0.021 | 0.373 | Xanthine oxidase inhibitor | 0.373 0.005 CID_124202061 | CID_124202061 | |
| 0.201 | 0.032 | 0.201 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.204 | 0.036 | 0.204 | Heat shock protein 90 antagonist | |||
| 0.207 | 0.04 | 0.207 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.187 | 0.02 | 0.375 | UDP-glucose 4-epimerase inhibitor | 0.375 0.007 CID_124202061 | CID_124202061 | |
| 0.215 | 0.049 | 0.215 | Histone acetyltransferase inhibitor | |||
| 0.275 | 0.11 | 0.443 | Vasodilator, coronary | 0.443 0.024 CID_124202061 | CID_124202061 | |
| 0.176 | 0.012 | 0.176 | Dopamine agonist | |||
| 0.215 | 0.051 | 0.215 | Growth factor agonist | |||
| 0.219 | 0.056 | 0.219 | Focal adhesion kinase 2 inhibitor | |||
| 0.185 | 0.023 | 0.185 | MAP3K9 inhibitor | |||
| 0.174 | 0.013 | 0.174 | Platelet growth factor antagonist | |||
| 0.187 | 0.026 | 0.187 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.255 | 0.096 | 0.277 | Hypoxia-inducible factor 1 alpha inhibitor | 0.277 0.079 CID_124202061 | CID_124202061 | |
| 0.203 | 0.045 | 0.203 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.161 | 0.004 | 0.161 | GABA B receptor agonist | |||
| 0.161 | 0.004 | 0.161 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.159 | 0.004 | 0.159 | Fatty acid synthase inhibitor | 0.091 0.014 CID_124202061 | ||
| 0.223 | 0.069 | 0.223 | Psychostimulant | 0.22 0.07 CID_124202061 | ||
| 0.172 | 0.018 | 0.172 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.171 | 0.017 | 0.179 | Heat shock protein 70 antagonist | 0.179 0.012 CID_124202061 | CID_124202061 | |
| 0.168 | 0.015 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 CID_124202061 | ||
| 0.235 | 0.082 | 0.592 | Tumour necrosis factor alpha release inhibitor | 0.592 0.008 CID_124202061 | CID_124202061 | |
| 0.181 | 0.028 | 0.181 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.174 | 0.021 | 0.174 | Antineoplastic alkaloid | |||
| 0.163 | 0.011 | 0.163 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.099 0.039 CID_124202061 | ||
| 0.174 | 0.023 | 0.174 | Platelet activating factor alpha antagonist | |||
| 0.192 | 0.041 | 0.192 | Arachidonic acid antagonist | |||
| 0.234 | 0.083 | 0.234 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.25 | 0.1 | 0.25 | Lipoxygenase inhibitor | |||
| 0.194 | 0.044 | 0.366 | Melanin inhibitor | 0.366 0.014 CID_124202061 | CID_124202061 | |
| 0.158 | 0.008 | 0.158 | I kappa B kinase 1 inhibitor | |||
| 0.176 | 0.027 | 0.176 | MAP kinase kinase 4 inhibitor | |||
| 0.212 | 0.065 | 0.212 | Tyrosine kinase inhibitor | |||
| 0.161 | 0.014 | 0.161 | CYP2A6 inhibitor | |||
| 0.2 | 0.052 | 0.2 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.159 | 0.013 | 0.159 | Macrophage migration inhibitory factor inhibitor | |||
| 0.159 | 0.012 | 0.159 | MAP-kinase-activated kinase inhibitor | |||
| 0.183 | 0.037 | 0.183 | Toll-Like receptor antagonist | |||
| 0.19 | 0.045 | 0.377 | Interferon gamma antagonist | 0.377 0.012 CID_124202061 | CID_124202061 | |
| 0.154 | 0.009 | 0.154 | Alpha tubulin antagonist | |||
| 0.147 | 0.004 | 0.147 | Cyclin D1 inhibitor | |||
| 0.165 | 0.022 | 0.165 | Adenylate kinase inhibitor | 0.111 0.052 CID_124202061 | ||
| 0.173 | 0.031 | 0.173 | Antibacterial (Helicobacter pylori) | 0.115 0.089 CID_124202061 | ||
| 0.148 | 0.008 | 0.148 | Protein kinase C eta inhibitor | 0.086 0.021 CID_124202061 | ||
| 0.145 | 0.006 | 0.145 | D-Ala-D-Ala ligase inhibitor | |||
| 0.18 | 0.042 | 0.193 | Alkaline phosphatase inhibitor | 0.193 0.036 CID_124202061 | CID_124202061 | |
| 0.168 | 0.031 | 0.168 | Ferrochelatase inhibitor | |||
| 0.169 | 0.032 | 0.169 | Alpha 2b adrenoreceptor antagonist | |||
| 0.169 | 0.033 | 0.169 | Protein kinase (CK2) alpha inhibitor | |||
| 0.175 | 0.039 | 0.175 | MAP kinase kinase inhibitor | |||
| 0.16 | 0.025 | 0.219 | Photosensitizer | 0.219 0.009 CID_124202061 | CID_124202061 | |
| 0.282 | 0.149 | 0.661 | Antibacterial | 0.661 0.012 CID_124202061 | CID_124202061 | |
| 0.189 | 0.056 | 0.189 | Heat shock protein 90 alpha antagonist | |||
| 0.173 | 0.041 | 0.173 | MAP kinase 3 inhibitor | |||
| 0.15 | 0.019 | 0.15 | CDC-like kinase 3 inhibitor | |||
| 0.144 | 0.012 | 0.144 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.19 | 0.059 | 0.19 | Tumour necrosis factor antagonist | |||
| 0.138 | 0.008 | 0.138 | Xanthine dehydrogenase inhibitor | 0.076 0.027 CID_124202061 | ||
| 0.159 | 0.032 | 0.159 | MAP kinase 13 inhibitor | |||
| 0.169 | 0.042 | 0.309 | Topoisomerase II inhibitor | 0.309 0.017 CID_124202061 | CID_124202061 | |
| 0.197 | 0.069 | 0.197 | CDC-like kinase 4 inhibitor | |||
| 0.176 | 0.049 | 0.176 | Activin receptor-like kinase 2 inhibitor | |||
| 0.177 | 0.051 | 0.295 | Hexokinase inhibitor | 0.295 0.011 CID_124202061 | CID_124202061 | |
| 0.133 | 0.008 | 0.133 | Beta 3 adrenoreceptor antagonist | |||
| 0.193 | 0.069 | 0.193 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.164 | 0.04 | 0.322 | Alkylator | 0.322 0.011 CID_124202061 | CID_124202061 | |
| 0.154 | 0.031 | 0.154 | Protein kinase (CK2) inhibitor | |||
| 0.127 | 0.004 | 0.127 | MAP kinase kinase 7 inhibitor | |||
| 0.165 | 0.042 | 0.469 | Monophenol monooxygenase inhibitor | 0.469 0.009 CID_124202061 | CID_124202061 | |
| 0.249 | 0.126 | 0.469 | Cholesterol antagonist | 0.469 0.038 CID_124202061 | CID_124202061 | |
| 0.13 | 0.008 | 0.13 | Bcl2 antagonist | 0.059 0.057 CID_124202061 | ||
| 0.162 | 0.04 | 0.163 | Interleukin 4 antagonist | 0.163 0.039 CID_124202061 | CID_124202061 | |
| 0.158 | 0.037 | 0.158 | MAP kinase 12 inhibitor | |||
| 0.17 | 0.049 | 0.17 | Mannose-6-phosphate isomerase inhibitor | 0.167 0.051 CID_124202061 | ||
| 0.159 | 0.038 | 0.285 | Topoisomerase I inhibitor | 0.285 0.012 CID_124202061 | CID_124202061 | |
| 0.135 | 0.014 | 0.135 | Beta tubulin antagonist | |||
| 0.155 | 0.036 | 0.155 | Interleukin 1b antagonist | 0.109 0.071 CID_124202061 | ||
| 0.172 | 0.054 | 0.345 | Protein kinase stimulant | 0.345 0.012 CID_124202061 | CID_124202061 | |
| 0.172 | 0.055 | 0.172 | Protein kinase (CK1) gamma inhibitor | |||
| 0.168 | 0.052 | 0.168 | Toll-Like receptor 9 antagonist | |||
| 0.173 | 0.058 | 0.173 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.12 | 0.005 | 0.12 | 5 Hydroxytryptamine 7 agonist | |||
| 0.133 | 0.017 | 0.133 | Check point kinase 1 inhibitor | |||
| 0.122 | 0.007 | 0.122 | Protein kinase C beta inhibitor | 0.071 0.045 CID_124202061 | ||
| 0.146 | 0.031 | 0.416 | AMP-activated protein kinase stimulant | 0.416 0.004 CID_124202061 | CID_124202061 | |
| 0.168 | 0.053 | 0.168 | MAO inhibitor | |||
| 0.137 | 0.022 | 0.137 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.139 | 0.024 | 0.139 | Alcohol dehydrogenase inhibitor | 0.125 0.032 CID_124202061 | ||
| 0.12 | 0.007 | 0.12 | Heat shock protein 90 beta antagonist | |||
| 0.13 | 0.018 | 0.13 | Glutamate decarboxylase inhibitor | |||
| 0.132 | 0.019 | 0.132 | Alpha adrenoreceptor agonist | |||
| 0.217 | 0.105 | 0.322 | Interleukin agonist | 0.322 0.038 CID_124202061 | CID_124202061 | |
| 0.12 | 0.009 | 0.12 | Dopamine D2 agonist | 0.061 0.02 CID_124202061 | ||
| 0.15 | 0.038 | 0.182 | Microtubule formation inhibitor | 0.182 0.025 CID_124202061 | CID_124202061 | |
| 0.134 | 0.022 | 0.222 | NADH dehydrogenase inhibitor | 0.222 0.009 CID_124202061 | CID_124202061 | |
| 0.12 | 0.008 | 0.12 | CC chemokine 5 receptor agonist | |||
| 0.143 | 0.033 | 0.143 | Carbonic anhydrase XV inhibitor | |||
| 0.185 | 0.076 | 0.185 | TRKC antagonist | |||
| 0.147 | 0.038 | 0.147 | Polo-like kinase-4 inhibitor | |||
| 0.133 | 0.024 | 0.133 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.134 | 0.025 | 0.219 | Triose-phosphate isomerase inhibitor | 0.219 0.009 CID_124202061 | CID_124202061 | |
| 0.144 | 0.038 | 0.144 | Chelator | |||
| 0.136 | 0.031 | 0.136 | Estrogen antagonist | |||
| 0.127 | 0.022 | 0.127 | Adrenaline agonist | |||
| 0.121 | 0.017 | 0.166 | Glycine receptor antagonist | 0.166 0.005 CID_124202061 | CID_124202061 | |
| 0.164 | 0.061 | 0.164 | Growth factor antagonist | |||
| 0.135 | 0.032 | 0.135 | Urease inhibitor | |||
| 0.24 | 0.138 | 0.504 | Apoptosis antagonist | 0.504 0.02 CID_124202061 | CID_124202061 | |
| 0.142 | 0.04 | 0.142 | GABA receptor agonist | |||
| 0.128 | 0.027 | 0.128 | Pim-3 kinase inhibitor | |||
| 0.134 | 0.034 | 0.134 | Pim-1 kinase inhibitor | |||
| 0.161 | 0.061 | 0.161 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.128 | 0.028 | 0.128 | MAP kinase kinase 1 inhibitor | |||
| 0.151 | 0.051 | 0.151 | Pregnane X receptor agonist | |||
| 0.111 | 0.012 | 0.111 | Alpha 2 adrenoreceptor agonist | |||
| 0.125 | 0.026 | 0.125 | Histamine N-methyltransferase inhibitor | |||
| 0.119 | 0.022 | 0.119 | Keratolytic | |||
| 0.147 | 0.05 | 0.147 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.122 | 0.026 | 0.122 | Acetylcholine nicotinic agonist | |||
| 0.142 | 0.046 | 0.151 | Beta amyloid protein antagonist | 0.151 0.04 CID_124202061 | CID_124202061 | |
| 0.119 | 0.024 | 0.119 | Bromodomain-containing protein 2 inhibitor | |||
| 0.126 | 0.032 | 0.126 | Hepatocyte growth factor antagonist | |||
| 0.099 | 0.004 | 0.099 | Dopamine D5 agonist | |||
| 0.155 | 0.061 | 0.155 | Ribosomal protein S6 kinase inhibitor | |||
| 0.12 | 0.026 | 0.12 | I kappa B kinase inhibitor | |||
| 0.113 | 0.022 | 0.113 | mTOR complex 2 inhibitor | |||
| 0.122 | 0.032 | 0.122 | Insulin growth factor antagonist | |||
| 0.099 | 0.009 | 0.099 | Topoisomerase II beta inhibitor | 0.073 0.015 CID_124202061 | ||
| 0.132 | 0.043 | 0.132 | EphA2 antagonist | 0.09 0.086 CID_124202061 | ||
| 0.183 | 0.094 | 0.183 | Platelet aggregation inhibitor | |||
| 0.109 | 0.02 | 0.109 | HIV-1 integrase inhibitor | |||
| 0.115 | 0.028 | 0.115 | MAP kinase 11 inhibitor | |||
| 0.13 | 0.044 | 0.13 | Transcription factor STAT6 inhibitor | |||
| 0.091 | 0.005 | 0.091 | Catechol O-methyltransferase inhibitor | |||
| 0.119 | 0.034 | 0.119 | Androgen antagonist | |||
| 0.139 | 0.053 | 0.139 | Adenylate cyclase inhibitor | |||
| 0.165 | 0.08 | 0.165 | Phospholipase C inhibitor | |||
| 0.107 | 0.023 | 0.107 | HIV-1 integrase (3'-Processing) inhibitor | 0.073 0.037 CID_124202061 | ||
| 0.106 | 0.024 | 0.106 | CDC25A inhibitor | |||
| 0.096 | 0.015 | 0.096 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.09 0.017 CID_124202061 | ||
| 0.148 | 0.068 | 0.296 | Cell wall synthesis inhibitor | 0.296 0.01 CID_124202061 | CID_124202061 | |
| 0.092 | 0.012 | 0.092 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.125 | 0.046 | 0.125 | Alpha 2c adrenoreceptor antagonist | |||
| 0.177 | 0.099 | 0.177 | Insulin sensitizer | 0.146 0.139 CID_124202061 | ||
| 0.096 | 0.018 | 0.096 | Beta adrenoreceptor antagonist | |||
| 0.091 | 0.013 | 0.091 | Phosphodiesterase 3B inhibitor | |||
| 0.127 | 0.049 | 0.127 | Falcipain 3 inhibitor | |||
| 0.142 | 0.065 | 0.142 | RET inhibitor | |||
| 0.115 | 0.038 | 0.115 | Estrogen receptor beta antagonist | |||
| 0.147 | 0.071 | 0.447 | Hemostatic | 0.447 0.005 CID_124202061 | CID_124202061 | |
| 0.111 | 0.035 | 0.172 | Phosphodiesterase 6D inhibitor | 0.172 0.006 CID_124202061 | CID_124202061 | |
| 0.082 | 0.008 | 0.082 | Ryanodine receptor antagonist | |||
| 0.098 | 0.023 | 0.098 | Protein kinase C alpha inhibitor | |||
| 0.08 | 0.006 | 0.08 | GABA B receptor antagonist | |||
| 0.119 | 0.046 | 0.119 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.088 | 0.016 | 0.088 | Protein kinase C epsilon inhibitor | |||
| 0.102 | 0.031 | 0.102 | NMDA 2 receptor antagonist | |||
| 0.094 | 0.023 | 0.094 | Aromatase inhibitor | |||
| 0.092 | 0.021 | 0.092 | Protein kinase C iota inhibitor | |||
| 0.105 | 0.034 | 0.105 | Alpha 2a adrenoreceptor antagonist | |||
| 0.135 | 0.064 | 0.135 | c-Src kinase inhibitor | |||
| 0.11 | 0.04 | 0.144 | Interleukin 12 antagonist | 0.144 0.014 CID_124202061 | CID_124202061 | |
| 0.107 | 0.037 | 0.107 | Insulin like growth factor 1 antagonist | |||
| 0.12 | 0.05 | 0.12 | 5-Lipoxygenase inhibitor | |||
| 0.121 | 0.051 | 0.121 | Activin receptor-like kinase 4 inhibitor | |||
| 0.084 | 0.015 | 0.084 | Beta 1 adrenoreceptor antagonist | |||
| 0.118 | 0.049 | 0.321 | Mediator release inhibitor | 0.321 0.006 CID_124202061 | CID_124202061 | |
| 0.203 | 0.134 | 0.203 | Transcription factor STAT inhibitor | |||
| 0.088 | 0.019 | 0.088 | Glutamate (mGluR7) antagonist | |||
| 0.143 | 0.074 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.09 | 0.022 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.088 | 0.022 | 0.088 | Potassium channel (ATP-sensitive) blocker | |||
| 0.074 | 0.007 | 0.074 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.092 | 0.026 | 0.092 | HIV-1 integrase (Strand Transfer) inhibitor | 0.066 0.038 CID_124202061 | ||
| 0.083 | 0.017 | 0.083 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.087 | 0.021 | 0.087 | Aryl hydrocarbon receptor antagonist | |||
| 0.136 | 0.071 | 0.136 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.088 | 0.023 | 0.088 | Argininosuccinate synthase inhibitor | |||
| 0.128 | 0.064 | 0.128 | Vascular endothelial growth factor antagonist | |||
| 0.072 | 0.009 | 0.072 | Purinergic P2X4 antagonist | |||
| 0.155 | 0.091 | 0.441 | Nitric oxide antagonist | 0.441 0.021 CID_124202061 | CID_124202061 | |
| 0.085 | 0.022 | 0.085 | NMDA 2C receptor antagonist | |||
| 0.101 | 0.039 | 0.21 | Topoisomerase II alpha inhibitor | 0.21 0.014 CID_124202061 | CID_124202061 | |
| 0.092 | 0.03 | 0.092 | Benzodiazepine agonist | |||
| 0.111 | 0.049 | 0.111 | Anabolic | |||
| 0.09 | 0.028 | 0.09 | Dopamine D1 antagonist | |||
| 0.07 | 0.008 | 0.07 | Dopamine beta hydroxylase inhibitor | |||
| 0.093 | 0.032 | 0.093 | Estrogen receptor alpha antagonist | |||
| 0.084 | 0.025 | 0.084 | CDC25B inhibitor | |||
| 0.103 | 0.044 | 0.103 | Bile acid receptor antagonist | |||
| 0.073 | 0.014 | 0.073 | Dihydroorotate oxidase inhibitor | |||
| 0.095 | 0.036 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.118 0.017 CID_124202061 | CID_124202061 | |
| 0.083 | 0.025 | 0.083 | 5 Hydroxytryptamine 3 agonist | |||
| 0.078 | 0.02 | 0.078 | Bromodomain-containing protein 4 inhibitor | |||
| 0.145 | 0.087 | 0.145 | Src kinase inhibitor | |||
| 0.066 | 0.009 | 0.066 | Alpha 1d adrenoreceptor agonist | |||
| 0.115 | 0.057 | 0.115 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.118 | 0.061 | 0.118 | TRPA1 agonist | |||
| 0.123 | 0.066 | 0.203 | DNA repair enzyme inhibitor | 0.203 0.008 CID_124202061 | CID_124202061 | |
| 0.072 | 0.016 | 0.072 | Beta 2 adrenoreceptor antagonist | |||
| 0.089 | 0.033 | 0.089 | Cyclin B3 inhibitor | |||
| 0.124 | 0.069 | 0.124 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.105 | 0.05 | 0.105 | Electrolyte absorption antagonist | |||
| 0.092 | 0.037 | 0.092 | Estrogen-related receptor beta agonist | |||
| 0.104 | 0.05 | 0.119 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.119 0.04 CID_124202061 | CID_124202061 | |
| 0.085 | 0.031 | 0.085 | Phosphodiesterase III inhibitor | |||
| 0.244 | 0.191 | 0.602 | Alpha-glucosidase inhibitor | 0.602 0.053 CID_124202061 | CID_124202061 | |
| 0.066 | 0.013 | 0.066 | CDK5/p25 inhibitor | |||
| 0.132 | 0.079 | 0.132 | Aurora-C kinase inhibitor | |||
| 0.149 | 0.096 | 0.149 | Dual specificity phosphatase inhibitor | |||
| 0.075 | 0.022 | 0.075 | Transcription factor RelA inhibitor | |||
| 0.077 | 0.024 | 0.077 | I kappa B kinase 2 inhibitor | |||
| 0.108 | 0.055 | 0.108 | Gastric antisecretory | |||
| 0.089 | 0.036 | 0.169 | Phosphofructokinase-1 inhibitor | 0.169 0.015 CID_124202061 | CID_124202061 | |
| 0.12 | 0.068 | 0.167 | DNA polymerase I inhibitor | 0.167 0.041 CID_124202061 | CID_124202061 | |
| 0.08 | 0.028 | 0.08 | 5 Hydroxytryptamine 2A agonist | |||
| 0.07 | 0.019 | 0.07 | Aconitate hydratase inhibitor | |||
| 0.11 | 0.059 | 0.11 | Aminopeptidase B inhibitor | |||
| 0.113 | 0.062 | 0.177 | DNA intercalator | 0.177 0.033 CID_124202061 | CID_124202061 | |
| 0.068 | 0.017 | 0.068 | Pregnane X receptor antagonist | |||
| 0.071 | 0.021 | 0.071 | Prolactin release inhibitor | |||
| 0.069 | 0.019 | 0.069 | 5 Hydroxytryptamine 1B agonist | |||
| 0.077 | 0.028 | 0.077 | Biliverdin reductase inhibitor | |||
| 0.089 | 0.04 | 0.089 | Rho-associated kinase inhibitor | |||
| 0.09 | 0.042 | 0.09 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.054 | 0.006 | 0.054 | Protein kinase (CK2) beta inhibitor | |||
| 0.065 | 0.017 | 0.065 | Alpha 1L adrenoreceptor antagonist | |||
| 0.089 | 0.041 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.09 | 0.042 | 0.09 | Catalase inhibitor | |||
| 0.081 | 0.033 | 0.081 | Phospholipase D inhibitor | |||
| 0.095 | 0.047 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 CID_124202061 | CID_124202061 | |
| 0.125 | 0.077 | 0.125 | Vanilloid 1 agonist | 0.116 0.096 CID_124202061 | ||
| 0.106 | 0.059 | 0.106 | Check point kinase 2 inhibitor | |||
| 0.097 | 0.05 | 0.097 | Alpha 2 adrenoreceptor antagonist | |||
| 0.101 | 0.054 | 0.101 | Breast cancer-resistant protein inhibitor | |||
| 0.127 | 0.08 | 0.127 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.081 | 0.035 | 0.081 | CDC7 inhibitor | |||
| 0.128 | 0.083 | 0.128 | Nav1.6 sodium channel blocker | |||
| 0.053 | 0.008 | 0.053 | Cyclin E2 inhibitor | |||
| 0.106 | 0.062 | 0.106 | Vascular endothelial growth factor 1 antagonist | |||
| 0.049 | 0.005 | 0.049 | Dopamine D1 agonist | 0.044 0.005 CID_124202061 | ||
| 0.102 | 0.058 | 0.102 | Insulin receptor antagonist | |||
| 0.067 | 0.025 | 0.067 | Beta 2 adrenoreceptor agonist | |||
| 0.114 | 0.071 | 0.114 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.079 | 0.037 | 0.079 | Neuronal nicotinic receptor antagonist | |||
| 0.07 | 0.028 | 0.07 | Alpha 1 adrenoreceptor agonist | |||
| 0.047 | 0.005 | 0.047 | Thyroid hormone agonist | |||
| 0.053 | 0.012 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.046 | 0.005 | 0.046 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.073 | 0.032 | 0.073 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.048 | 0.008 | 0.048 | Dopamine autoreceptor agonist | |||
| 0.083 | 0.042 | 0.083 | Janus tyrosine kinase 3 inhibitor | |||
| 0.062 | 0.021 | 0.062 | Immunoglobulin Fc receptor antagonist | |||
| 0.082 | 0.042 | 0.082 | Glutamate dehydrogenase inhibitor | |||
| 0.125 | 0.087 | 0.125 | Protein kinase (CK1) inhibitor | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.211 | 0.174 | 0.211 | Sodium/bile acid cotransporter inhibitor | |||
| 0.21 | 0.173 | 0.421 | Interleukin 2 agonist | 0.421 0.022 CID_124202061 | CID_124202061 | |
| 0.069 | 0.032 | 0.069 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.069 | 0.033 | 0.069 | Purinergic P2X1 antagonist | |||
| 0.064 | 0.028 | 0.064 | Cyclin B2 inhibitor | |||
| 0.087 | 0.052 | 0.087 | GABA A receptor agonist | |||
| 0.206 | 0.17 | 0.633 | Antithrombotic | 0.633 0.013 CID_124202061 | CID_124202061 | |
| 0.091 | 0.056 | 0.091 | Phosphodiesterase I inhibitor | |||
| 0.083 | 0.048 | 0.083 | Somatostatin 1 agonist | |||
| 0.063 | 0.029 | 0.063 | GABA receptor antagonist | |||
| 0.067 | 0.033 | 0.067 | Androgen agonist | |||
| 0.088 | 0.054 | 0.088 | Bcr-Abl kinase inhibitor | |||
| 0.136 | 0.102 | 0.136 | Polo-like kinase-3 inhibitor | |||
| 0.096 | 0.062 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.057 | 0.023 | 0.057 | Adenosine deaminase inhibitor | 0.045 0.035 CID_124202061 | ||
| 0.098 | 0.064 | 0.098 | Platelet activating factor beta antagonist | |||
| 0.068 | 0.035 | 0.068 | TRPA1 antagonist | |||
| 0.111 | 0.08 | 0.111 | Cyclin-dependent kinase inhibitor | |||
| 0.091 | 0.059 | 0.091 | Polo-like kinase-1 inhibitor | |||
| 0.136 | 0.105 | 0.136 | Mcl-1 antagonist | |||
| 0.105 | 0.075 | 0.105 | Platelet activating factor antagonist | |||
| 0.053 | 0.023 | 0.053 | NMDA receptor subunit 3B antagonist | |||
| 0.096 | 0.066 | 0.096 | Ephrin antagonist | |||
| 0.087 | 0.057 | 0.087 | NMDA receptor antagonist | |||
| 0.102 | 0.073 | 0.102 | Nav1.4 sodium channel blocker | |||
| 0.173 | 0.143 | 0.315 | Spasmolytic | 0.315 0.064 CID_124202061 | CID_124202061 | |
| 0.105 | 0.076 | 0.105 | Aurora-B kinase inhibitor | |||
| 0.093 | 0.064 | 0.093 | MAO B inhibitor | |||
| 0.075 | 0.046 | 0.075 | MAP3K7 inhibitor | |||
| 0.066 | 0.037 | 0.066 | Cyclin B1 inhibitor | |||
| 0.068 | 0.04 | 0.068 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.076 | 0.048 | 0.088 | Phosphodiesterase VI inhibitor | 0.088 0.03 CID_124202061 | CID_124202061 | |
| 0.044 | 0.017 | 0.044 | Phosphoglycerate kinase inhibitor | |||
| 0.039 | 0.011 | 0.039 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.076 | 0.048 | 0.124 | Histone deacetylase stimulant | 0.124 0.016 CID_124202061 | CID_124202061 | |
| 0.076 | 0.048 | 0.124 | Histone deacetylase SIRT1 stimulant | 0.124 0.016 CID_124202061 | CID_124202061 | |
| 0.099 | 0.072 | 0.099 | Vascular endothelial growth factor 2 antagonist | |||
| 0.081 | 0.054 | 0.081 | Acetylcholine nicotinic antagonist | |||
| 0.102 | 0.075 | 0.132 | Mucolytic | 0.132 0.044 CID_124202061 | CID_124202061 | |
| 0.059 | 0.032 | 0.059 | GABA A receptor antagonist | |||
| 0.061 | 0.035 | 0.061 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.098 | 0.072 | 0.098 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.034 | 0.009 | 0.034 | Thymidine phosphorylase inhibitor | |||
| 0.072 | 0.046 | 0.072 | Protein kinase B alpha inhibitor | |||
| 0.063 | 0.038 | 0.063 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.048 | 0.023 | 0.048 | Beta adrenoreceptor agonist | |||
| 0.05 | 0.025 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.047 | 0.023 | 0.047 | DNA-dependent protein kinase inhibitor | |||
| 0.073 | 0.049 | 0.073 | Aminopeptidase I inhibitor | |||
| 0.076 | 0.053 | 0.13 | Carbonic anhydrase XIII inhibitor | 0.13 0.026 CID_124202061 | CID_124202061 | |
| 0.035 | 0.011 | 0.035 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.048 | 0.025 | 0.048 | AICAR transformylase inhibitor | |||
| 0.059 | 0.036 | 0.059 | Nicotinic neuronal receptor agonist | |||
| 0.056 | 0.034 | 0.056 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.123 | 0.101 | 0.123 | Death-associated protein kinase 1 inhibitor | |||
| 0.057 | 0.035 | 0.057 | Pim-2 kinase inhibitor | |||
| 0.046 | 0.024 | 0.046 | Glutamate (mGluR1a) antagonist | |||
| 0.058 | 0.037 | 0.058 | Carbonic anhydrase VB inhibitor | |||
| 0.073 | 0.052 | 0.073 | Protein kinase B beta inhibitor | |||
| 0.059 | 0.038 | 0.059 | Botulinum neurotoxin type A inhibitor | |||
| 0.142 | 0.122 | 0.157 | Anesthetic general | 0.157 0.106 CID_124202061 | CID_124202061 | |
| 0.099 | 0.079 | 0.099 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.046 | 0.026 | 0.046 | Histamine H2 receptor agonist | |||
| 0.05 | 0.03 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.065 0.015 CID_124202061 | CID_124202061 | |
| 0.06 | 0.04 | 0.06 | Carbonic anhydrase stimulant | |||
| 0.041 | 0.022 | 0.041 | CF transmembrane conductance regulator antagonist | |||
| 0.041 | 0.022 | 0.041 | Progesterone antagonist | |||
| 0.099 | 0.08 | 0.099 | Glycogen synthase kinase-3 inhibitor | |||
| 0.082 | 0.063 | 0.082 | Epidermal growth factor antagonist | |||
| 0.056 | 0.038 | 0.056 | Cyclin B inhibitor | |||
| 0.054 | 0.036 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.033 | 0.015 | 0.033 | Uridine phosphorylase inhibitor | 0.025 0.022 CID_124202061 | ||
| 0.053 | 0.036 | 0.053 | 5 Hydroxytryptamine 1 agonist | |||
| 0.036 | 0.019 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.108 | 0.091 | 0.257 | Cyclooxygenase 3 inhibitor | 0.257 0.008 CID_124202061 | CID_124202061 | |
| 0.154 | 0.137 | 0.154 | MAP kinase kinase 5 inhibitor | |||
| 0.1 | 0.083 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.084 | 0.069 | 0.084 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.084 | 0.069 | 0.084 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.034 | 0.019 | 0.034 | ATR kinase inhibitor | |||
| 0.08 | 0.065 | 0.08 | Transforming growth factor beta 3 antagonist | |||
| 0.04 | 0.025 | 0.04 | Histone deacetylase 9 inhibitor | |||
| 0.039 | 0.024 | 0.039 | Histone deacetylase 7 inhibitor | |||
| 0.035 | 0.021 | 0.035 | Glucocorticoid antagonist | |||
| 0.041 | 0.026 | 0.041 | Dopamine D3 agonist | |||
| 0.022 | 0.008 | 0.022 | Alpha 2b adrenoreceptor agonist | |||
| 0.083 | 0.069 | 0.083 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.051 | 0.037 | 0.051 | NMDA 2A receptor antagonist | |||
| 0.117 | 0.104 | 0.117 | Cytidine deaminase inhibitor | |||
| 0.077 | 0.064 | 0.077 | ALK inhibitor | |||
| 0.068 | 0.055 | 0.068 | Polo-like kinase-2 inhibitor | |||
| 0.062 | 0.049 | 0.062 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.057 | 0.045 | 0.057 | Bombesin 1 receptor agonist | |||
| 0.065 | 0.053 | 0.065 | Carbonic anhydrase VA inhibitor | |||
| 0.046 | 0.034 | 0.046 | Benzodiazepine inverse agonist | |||
| 0.069 | 0.057 | 0.069 | Nav1.8 sodium channel blocker | |||
| 0.05 | 0.038 | 0.05 | mTOR inhibitor | |||
| 0.049 | 0.038 | 0.049 | CD45 antagonist | |||
| 0.032 | 0.021 | 0.032 | ATP citrate lysase inhibitor | |||
| 0.065 | 0.054 | 0.065 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.05 | 0.039 | 0.111 | Glucose-6-phosphate translocase inhibitor | 0.111 0.005 CID_124202061 | CID_124202061 | |
| 0.042 | 0.031 | 0.042 | Glutamate (mGluR group III) agonist | |||
| 0.034 | 0.023 | 0.034 | Glutamate (mGluR4) agonist | |||
| 0.085 | 0.074 | 0.14 | Uric acid excretion stimulant | 0.14 0.027 CID_124202061 | CID_124202061 | |
| 0.02 | 0.009 | 0.02 | Alpha 2a adrenoreceptor agonist | |||
| 0.043 | 0.032 | 0.043 | Histamine H1 receptor agonist | |||
| 0.14 | 0.129 | 0.741 | Angiogenesis stimulant | 0.741 0.004 CID_124202061 | CID_124202061 | |
| 0.044 | 0.034 | 0.044 | Adenylate cyclase 1 inhibitor | |||
| 0.054 | 0.044 | 0.054 | EphB4 antagonist | |||
| 0.022 | 0.012 | 0.022 | Imidazoline I1 receptor antagonist | |||
| 0.055 | 0.045 | 0.055 | Dopamine D4 antagonist | |||
| 0.059 | 0.049 | 0.059 | NMDA receptor agonist | |||
| 0.04 | 0.031 | 0.04 | Kainate receptor agonist | |||
| 0.03 | 0.02 | 0.03 | Glucagon receptor antagonist | |||
| 0.013 | 0.004 | 0.013 | Thyroid hormone beta agonist | |||
| 0.082 | 0.073 | 0.082 | Potassium channel (Ca-activated) activator | |||
| 0.033 | 0.023 | 0.033 | Melatonin 2 agonist | |||
| 0.041 | 0.032 | 0.041 | Nerve growth factor antagonist | |||
| 0.06 | 0.051 | 0.06 | Fibroblast growth factor 2 antagonist | |||
| 0.064 | 0.055 | 0.064 | Syk tyrosine kinase inhibitor | |||
| 0.165 | 0.156 | 0.165 | Calpain inhibitor | |||
| 0.039 | 0.031 | 0.039 | Liver X receptor alpha agonist | |||
| 0.033 | 0.024 | 0.033 | Protein kinase C beta I inhibitor | 0.032 0.027 CID_124202061 | ||
| 0.08 | 0.071 | 0.08 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.037 | 0.028 | 0.037 | Glutamate (mGluR8) agonist | |||
| 0.046 | 0.038 | 0.046 | Transforming growth factor beta 1 antagonist | |||
| 0.038 | 0.03 | 0.038 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.033 | 0.026 | 0.033 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.052 | 0.044 | 0.052 | Epithelial sodium channel blocker | |||
| 0.038 | 0.031 | 0.038 | Histone deacetylase 8 inhibitor | |||
| 0.045 | 0.038 | 0.045 | Mineralocorticoid receptor antagonist | |||
| 0.042 | 0.035 | 0.042 | Dihydroorotase inhibitor | |||
| 0.019 | 0.012 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.059 | 0.052 | 0.059 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.105 | 0.098 | 0.105 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.056 | 0.05 | 0.056 | NMDA receptor glycine site agonist | |||
| 0.022 | 0.016 | 0.022 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.051 | 0.045 | 0.051 | Sphingosine kinase 2 inhibitor | |||
| 0.054 | 0.047 | 0.054 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.064 | 0.057 | 0.064 | Alpha 1b adrenoreceptor antagonist | |||
| 0.084 | 0.078 | 0.084 | Glutamate release inhibitor | 0.083 0.081 CID_124202061 | ||
| 0.031 | 0.025 | 0.031 | Estrogen-related receptor beta antagonist | |||
| 0.086 | 0.081 | 0.086 | Alpha 2d adrenoreceptor antagonist | |||
| 0.022 | 0.017 | 0.022 | Beta 1 adrenoreceptor agonist | |||
| 0.052 | 0.047 | 0.052 | CDK4/cyclin D1 inhibitor | |||
| 0.064 | 0.06 | 0.064 | MDM2 inhibitor | |||
| 0.058 | 0.054 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.063 | 0.06 | 0.063 | Amidase inhibitor | |||
| 0.064 | 0.061 | 0.064 | Raf kinase inhibitor | |||
| 0.034 | 0.031 | 0.034 | NMDA receptor subunit 3A antagonist | |||
| 0.071 | 0.068 | 0.081 | Interferon agonist | 0.081 0.05 CID_124202061 | CID_124202061 | |
| 0.018 | 0.015 | 0.018 | Somatostatin 3 agonist | |||
| 0.096 | 0.093 | 0.096 | Cholesterol synthesis inhibitor | |||
| 0.024 | 0.022 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.017 | 0.015 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.015 | 0.013 | 0.015 | Nicotinic alpha4 receptor agonist | |||
| 0.006 | 0.004 | 0.006 | Insulin like growth factor 3 antagonist | |||
| 0.12 | 0.119 | 0.152 | CC chemokine 6 receptor antagonist | 0.152 0.02 CID_124202061 | CID_124202061 | |
| 0.065 | 0.064 | 0.065 | Rho-associated kinase II inhibitor | |||
| 0.153 | 0.153 | 0.373 | Vasodilator | 0.373 0.028 CID_124202061 | CID_124202061 | |
| 0.115 | 0.116 | 0.364 | Thrombolytic | 0.364 0.015 CID_124202061 | CID_124202061 | |
| 0.008 | 0.014 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_124202061 | CID_124202061 | |
| 0.083 | 0.091 | 0.324 | Expectorant | 0.324 0.007 CID_124202061 | CID_124202061 | |
| 0.034 | 0.045 | 0.096 | Phosphorylase inhibitor | 0.096 0.014 CID_124202061 | CID_124202061 | |
| 0.046 | 0.057 | 0.117 | Heparanase inhibitor | 0.117 0.003 CID_124202061 | CID_124202061 | |
| 0.022 | 0.033 | 0.079 | Sodium/glucose cotransporter inhibitor | 0.079 0.004 CID_124202061 | CID_124202061 | |
| 0.044 | 0.058 | 0.078 | Alpha-mannosidase inhibitor | 0.078 0.012 CID_124202061 | CID_124202061 | |
| 0.012 | 0.027 | 0.017 | Telomerase stimulant | 0.017 0.012 CID_124202061 | CID_124202061 | |
| 0.054 | 0.07 | 0.061 | Interferon inducer | 0.061 0.052 CID_124202061 | CID_124202061 | |
| 0.144 | 0.16 | 0.442 | Immunostimulant | 0.442 0.039 CID_124202061 | CID_124202061 | |
| 0.02 | 0.036 | 0.031 | Vanilloid 2 agonist | 0.031 0.009 CID_124202061 | CID_124202061 | |
| 0.158 | 0.174 | 0.392 | Peptidyltransferase inhibitor | 0.392 0.007 CID_124202061 | CID_124202061 | |
| 0.037 | 0.054 | 0.064 | Carbonic anhydrase XIV inhibitor | 0.064 0.022 CID_124202061 | CID_124202061 | |
| 0.131 | 0.149 | 0.36 | Non-steroidal antiinflammatory agent | 0.36 0.018 CID_124202061 | CID_124202061 | |
| 0.084 | 0.102 | 0.17 | Toll-Like receptor 4 antagonist | 0.17 0.013 CID_124202061 | CID_124202061 | |
| 0.109 | 0.127 | 0.14 | Protein-tyrosine phosphatase inhibitor | 0.14 0.09 CID_124202061 | CID_124202061 | |
| 0.048 | 0.066 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 CID_124202061 | CID_124202061 | |
| 0.075 | 0.096 | 0.12 | Thioredoxin inhibitor | 0.12 0.03 CID_124202061 | CID_124202061 | |
| 0.033 | 0.056 | 0.075 | Mannosidase inhibitor | 0.075 0.01 CID_124202061 | CID_124202061 | |
| 0.047 | 0.076 | 0.062 | Transcription factor AP-1 inhibitor | 0.062 0.041 CID_124202061 | CID_124202061 | |
| 0.008 | 0.038 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 CID_124202061 | CID_124202061 | |
| 0.028 | 0.06 | 0.043 | Estrogen agonist | 0.043 0.04 CID_124202061 | CID_124202061 | |
| 0.013 | 0.047 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_124202061 | CID_124202061 | |
| 0.016 | 0.051 | 0.048 | Arginase inhibitor | 0.048 0.016 CID_124202061 | CID_124202061 | |
| 0.04 | 0.078 | 0.056 | Factor III inhibitor | 0.056 0.023 CID_124202061 | CID_124202061 | |
| 0.178 | 0.22 | 0.492 | Immunosuppressant | 0.492 0.035 CID_124202061 | CID_124202061 | |
| 0.047 | 0.091 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 CID_124202061 | CID_124202061 | |
| 0.014 | 0.06 | 0.065 | Sodium/glucose cotransporter 2 inhibitor | 0.065 0.005 CID_124202061 | CID_124202061 | |
| 0.027 | 0.078 | 0.087 | Aldose reductase inhibitor | 0.087 0.021 CID_124202061 | CID_124202061 | |
| 0.066 | 0.126 | 0.121 | Protein-tyrosine phosphatase 1B inhibitor | 0.121 0.063 CID_124202061 | CID_124202061 | |
| 0.031 | 0.098 | 0.361 | Selectin antagonist | 0.361 0.004 CID_124202061 | CID_124202061 | |
| 0.107 | 0.178 | 0.449 | Hepatoprotectant | 0.449 0.01 CID_124202061 | CID_124202061 | |
| 0.098 | 0.179 | 0.407 | Platelet adhesion inhibitor | 0.407 0.011 CID_124202061 | CID_124202061 | |
| 0.033 | 0.115 | 0.207 | Antineoplastic antibiotic | 0.207 0.02 CID_124202061 | CID_124202061 | |
| 0.086 | 0.175 | 0.176 | Diuretic | 0.176 0.056 CID_124202061 | CID_124202061 | |
| 0.03 | 0.121 | 0.093 | Factor IXa inhibitor | 0.093 0.012 CID_124202061 | CID_124202061 | |
| 0.049 | 0.164 | 0.083 | Falcipain 2 inhibitor | 0.083 0.066 CID_124202061 | CID_124202061 | |
| 0.062 | 0.178 | 0.111 | Multidrug resistance-associated protein 1 inhibitor | 0.111 0.061 CID_124202061 | CID_124202061 | |
| 0.051 | 0.168 | 0.085 | Falcipain inhibitor | 0.085 0.068 CID_124202061 | CID_124202061 | |
| 0.062 | 0.188 | 0.086 | T cell inhibitor | 0.086 0.047 CID_124202061 | CID_124202061 | |
| 0.01 | 0.154 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_124202061 | CID_124202061 | |
| 0.131 | 0.275 | 0.443 | Immunomodulator | 0.443 0.033 CID_124202061 | CID_124202061 | |
| 0.028 | 0.195 | 0.058 | DNA gyrase inhibitor | 0.058 0.052 CID_124202061 | CID_124202061 | |
| 0.015 | 0.185 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 CID_124202061 | CID_124202061 | |
| 0.102 | 0.276 | 0.603 | Hypoglycemic | 0.603 0.008 CID_124202061 | CID_124202061 | |
| 0.016 | 0.215 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.024 CID_124202061 | CID_124202061 | |
| 0.009 | 0.211 | 0.051 | Protein 30S ribosomal subunit inhibitor | 0.051 0.008 CID_124202061 | CID_124202061 | |
| 0.021 | 0.225 | 0.078 | Neuraminidase (influenza) inhibitor | 0.078 0.027 CID_124202061 | CID_124202061 | |
| 0.072 | 0.288 | 0.231 | Insulin secretagoues | 0.231 0.024 CID_124202061 | CID_124202061 | |
| 0.115 | 0.349 | 0.28 | Toll-Like receptor 7 agonist | 0.28 0.124 CID_124202061 | CID_124202061 | |
| 0.015 | 0.249 | 0.042 | Microtubule stabilization | 0.042 0.039 CID_124202061 | CID_124202061 | |
| 0.112 | 0.353 | 0.302 | Toll-Like receptor agonist | 0.302 0.11 CID_124202061 | CID_124202061 | |
| 0.012 | 0.258 | 0.069 | Neuraminidase inhibitor | 0.069 0.035 CID_124202061 | CID_124202061 | |
| 0.044 | 0.304 | 0.144 | Transcription factor NF kappa B stimulant | 0.144 0.017 CID_124202061 | CID_124202061 | |
| 0.133 | 0.395 | 0.738 | Cyclophilin D inhibitor | 0.738 0.011 CID_124202061 | CID_124202061 | |
| 0.015 | 0.328 | 0.073 | Antibiotic Aminoglycoside-like | 0.073 0.005 CID_124202061 | CID_124202061 | |
| 0.013 | 0.335 | 0.098 | Protein 50S ribosomal subunit inhibitor | 0.098 0.013 CID_124202061 | CID_124202061 | |
| 0.045 | 0.394 | 0.285 | Platelet antagonist | 0.285 0.058 CID_124202061 | CID_124202061 | |
| 0.014 | 0.392 | 0.06 | Nitric oxide donor | 0.06 0.048 CID_124202061 | CID_124202061 | |
| 0.03 | 0.434 | 0.23 | Anticoagulant | 0.23 0.043 CID_124202061 | CID_124202061 | |
| 0.03 | 0.483 | 0.198 | Cell adhesion inhibitor | 0.198 0.025 CID_124202061 | CID_124202061 | |
| 0.01 | 0.606 | 0.084 | Cell adhesion molecule inhibitor | 0.084 0.048 CID_124202061 | CID_124202061 | |
| 0.01 | 0.707 | 0.165 | Hypolipemic | 0.165 0.123 CID_124202061 | CID_124202061 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |